Development of an intranasal, universal influenza vaccine in an EU-funded public-private partnership: the FLUniversal consortium

Development of an intranasal, universal influenza vaccine in an EU-funded public-private partnership: the FLUniversal consortium

Influenza is a significant global health problem, causing disease and hospitalisations in elderly individuals and infants. While updated vaccines are available every year, their effectiveness is moderate at best. FLUniversal is a European Union funded consortium, aiming to develop a universal influe...

Full description

Saved in:
Bibliographic Details
Main Authors: Victor M. Cnossen, Paula C. Leao Moreira, Othmar G. Engelhardt, Jerzy Samolej, Geert H. Groeneveld, Simon P. Jochems, Wesley Huisman, Gabriel K. Pedersen, Katharina Wørzner, Lukas Recek, Giulia Piccini, Claudia M. Trombetta, Amy Aspelund, Alaura Hoag, Manfred Reiter, Carrie Wick, Thomas Muster, Ingrid Maria Catharina Kamerling
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Immunology
Subjects:
influenza
vaccine
universal influenza vaccine
FLUniversal
controlled human infection model
public-private partnerships
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1568778/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2025.1568778/full

Similar Items